Phospho-Histone H3 (Thr6) Antibody

What is the significance of Histone H3 phosphorylation at Threonine 6?

Phosphorylation of Histone H3 at Threonine 6 (pH3T6) represents a critical post-translational modification involved in multiple cellular processes. This modification has been linked to mitosis, chromosome condensation, and gene transcription regulation . Unlike some other histone modifications, pH3T6 exhibits specific temporal and spatial distribution patterns during the cell cycle. Research has shown that dysregulation of this post-translational modification is associated with cancer progression and other pathological conditions, making it an important biomarker in oncology research . The phosphorylation status at this residue can provide insights into cell cycle control mechanisms, DNA damage response, and epigenetic regulation patterns.

How does Phospho-Histone H3 (Thr6) Antibody differ from antibodies targeting other H3 phosphorylation sites?

Phospho-Histone H3 (Thr6) antibody specifically recognizes histone H3 when phosphorylated at the threonine 6 residue, distinguishing it from antibodies targeting other phosphorylation sites such as Ser10, Ser28, Thr3, or Thr11. Each phospho-specific antibody has unique epitope recognition properties and exhibits distinct patterns of immunoreactivity during different cellular processes. For example, while pH3S10 antibodies are widely used as mitotic markers , pH3T6 antibodies detect modifications that may occur in both mitotic and non-mitotic contexts.

When designing multiplexed experiments, it's important to consider potential antibody occlusion effects, as densely distributed multiple modifications can negatively impact antibody recognition . This is particularly relevant when studying the combinatorial patterns of various histone modifications. Cross-reactivity testing with peptides containing different modification patterns is recommended to ensure specificity when using these antibodies in experimental protocols.

What are the recommended applications for Phospho-Histone H3 (Thr6) Antibody?

Phospho-Histone H3 (Thr6) antibodies have been validated primarily for Western blot (WB) applications . For optimal results in Western blotting, a dilution of 1:1000 is typically recommended . The antibody can detect endogenous levels of histone H3 phosphorylated at Thr6 in human, mouse, and rat samples.

While immunohistochemistry (IHC) applications are mentioned in some product specifications , researchers should perform thorough validation when applying these antibodies to tissue sections. Unlike some other histone modification antibodies (such as pH3S10 antibodies which have dedicated IHC detection kits ), standardized protocols for pH3T6 detection in tissue samples may require optimization. This typically involves testing different antigen retrieval methods, antibody concentrations, and detection systems to achieve optimal signal-to-background ratios.

What is the best sample preparation method for detecting Phospho-Histone H3 (Thr6)?

For optimal detection of phosphorylated Histone H3 at Thr6, sample preparation should preserve phosphorylation status while efficiently extracting histones. A recommended protocol includes:

• Harvest cells during appropriate cell cycle stages (consider synchronization if studying cell cycle-dependent changes)

• Include phosphatase inhibitors (such as sodium fluoride, sodium orthovanadate, and β-glycerophosphate) in all buffers

• For Western blot applications, employ acid extraction methods using 0.2M H₂SO₄ or Triton extraction protocols specifically designed for histones

• For fixed samples (IHC/IF), use freshly prepared 4% paraformaldehyde for 10-15 minutes and include phosphatase inhibitors during fixation

• Store samples at -80°C with protease and phosphatase inhibitors to prevent degradation

The timing of sample collection is critical, as phosphorylation levels may fluctuate during different cellular processes and cell cycle stages. If examining mitotic populations, consider nocodazole synchronization protocols to enrich for cells with condensed chromosomes .

How can I quantitatively analyze changes in Histone H3 Thr6 phosphorylation across different experimental conditions?

Quantitative analysis of pH3T6 requires careful experimental design and appropriate normalization strategies. A comprehensive approach includes:

• Experimental Design Considerations:

  • Include both biological and technical replicates (minimum n=3 for each)

  • Design time-course experiments to capture dynamic changes

  • Include appropriate controls (positive controls: mitotic-enriched samples; negative controls: phosphatase-treated samples)

• Western Blot Quantification Method:

  • Use standardized loading controls (total H3 or other stable references)

  • Employ densitometry software (ImageJ/Fiji) with background subtraction

  • Calculate pH3T6/total H3 ratios to normalize for loading variations

  • Analyze data using appropriate statistical tests (ANOVA with post-hoc tests for multiple comparisons)

• Imaging-Based Quantification:

  • For microscopy data, measure nuclear fluorescence intensity across ≥100 cells per condition

  • Use automated high-content screening approaches for large-scale analysis

  • Calculate signal-to-background ratios by comparing nuclear and cytoplasmic intensities

  • Generate distribution plots rather than simple averages to capture population heterogeneity

• Mass Spectrometry Validation:

  • For absolute quantification, consider targeted MS approaches using synthetic phosphopeptide standards

  • Apply correction factors to account for ionization differences between modified and unmodified peptides

Note that antibody occlusion can affect quantification accuracy when multiple neighboring modifications are present . If possible, validate key findings using orthogonal methods such as mass spectrometry or genetic approaches (phospho-mimetic mutations).

What are the known upstream kinases responsible for Histone H3 Thr6 phosphorylation and how should I study them?

While the specific kinases responsible for H3T6 phosphorylation have not been comprehensively characterized in the provided search results, research methodologies to identify and validate these kinases include:

• Kinase Inhibitor Screening:

  • Test a panel of cell-permeable kinase inhibitors and monitor H3T6 phosphorylation status

  • Include specific inhibitors targeting PKC family members, as PKC has been correlated with H3T6 phosphorylation in GBM samples

  • Use concentration gradients to establish dose-response relationships

  • Validate hits with secondary assays (direct kinase assays, genetic knockdown)

• In Vitro Kinase Assays:

  • Perform in vitro kinase reactions using recombinant H3 substrates and candidate kinases

  • Include controls such as kinase-dead mutants and non-phosphorylatable H3 mutants (T6A)

  • Quantify phosphorylation using phospho-specific antibodies or mass spectrometry

  • For comparison, include known kinase-substrate pairs like Haspin-H3T3 as positive controls

• Genetic Approaches:

  • Implement siRNA/shRNA knockdown or CRISPR-Cas9 knockout of candidate kinases

  • Generate phospho-mimetic (T6E or T6D) and non-phosphorylatable (T6A) H3 mutants to study functional consequences

  • Consider inducible expression systems for temporal control

Recent research has identified kinases like KimH3, which can phosphorylate Histone H3 at specific residues in both interphase and mitosis . Similar approaches could be applied to identify kinases responsible for H3T6 phosphorylation.

How does Histone H3 Thr6 phosphorylation correlate with disease progression in cancer models?

The prognostic value of Histone H3 Thr6 phosphorylation has been investigated in several cancer types, with significant findings in glioblastoma multiforme (GBM):

To establish similar correlations in other cancer types, researchers should:

• Use tissue microarrays for high-throughput analysis

• Validate antibody specificity in tissue sections with appropriate controls

• Correlate phosphorylation patterns with other established biomarkers

• Consider single-cell approaches to account for tumor heterogeneity

How can I design experiments to investigate the functional consequences of Histone H3 Thr6 phosphorylation on gene expression?

To establish causal relationships between H3T6 phosphorylation and transcriptional outcomes:

• Chromatin Immunoprecipitation (ChIP) Studies:

  • Perform ChIP-seq using pH3T6 antibodies to map genome-wide distribution

  • Integrate with transcriptome data (RNA-seq) from the same cellular context

  • Include controls for antibody specificity (peptide competition assays)

  • Compare pH3T6 enrichment patterns with other histone modifications (H3K4me3, H3K27ac) and transcription factors

  • Analyze pH3T6 distribution in promoter regions, gene bodies, and enhancers

• Genetic Engineering Approaches:

  • Generate cells expressing H3 variants with T6A (non-phosphorylatable) or T6E/T6D (phospho-mimetic) mutations

  • Use histone replacement systems to minimize effects of endogenous H3

  • Perform RNA-seq to identify differentially expressed genes

  • Validate key target genes with RT-qPCR and reporter assays

• Temporal Analysis During Cellular Transitions:

  • Design time-course experiments during processes like differentiation or stress response

  • Collect samples at regular intervals for both ChIP-seq and RNA-seq

  • Correlate dynamic changes in H3T6 phosphorylation with transcriptional waves

  • Compare with nucleosomal response mechanisms observed for other modifications like H3S10 phosphorylation

• Combinatorial Modification Analysis:

  • Investigate how H3T6 phosphorylation affects or is affected by neighboring modifications

  • Consider antibody occlusion effects when analyzing closely spaced modifications

  • Use sequential ChIP (re-ChIP) to identify genomic regions with co-occurring modifications

  • Apply mass spectrometry approaches to quantify combinatorial histone modification patterns

When interpreting results, consider that phosphorylation may affect transcription through multiple mechanisms, including direct changes in chromatin structure, recruitment of specific readers, or displacement of other chromatin-binding proteins.

What methodological considerations are important when comparing different Phospho-Histone H3 antibodies in multiplexed experiments?

When designing multiplexed experiments to study multiple histone H3 phosphorylation sites simultaneously:

• Antibody Validation and Compatibility:

  • Validate each antibody individually using positive controls (e.g., mitotic cells for mitotic markers)

  • Test for cross-reactivity using peptide arrays with various modifications

  • Consider antibody isotypes and species for secondary antibody selection

  • Evaluate potential antibody occlusion effects with neighboring modifications

• Technical Considerations for Immunofluorescence Multiplexing:

  • Use antibodies raised in different host species to avoid cross-reactivity

  • If same-species antibodies are necessary, consider sequential staining with intermediate blocking steps

  • Carefully select fluorophores with minimal spectral overlap

  • Include single-stained controls for spectral unmixing

  • Validate signal-to-background ratios for each antibody (typically >2.0 is considered acceptable)

• Flow Cytometry Applications:

  • Optimize fixation and permeabilization conditions for intracellular histone epitopes

  • Titrate antibodies to determine optimal concentrations

  • Use isotype controls to establish background thresholds

  • Consider cell cycle analysis in parallel (using DNA content staining)

  • Validate with synchronized cell populations (e.g., nocodazole arrest)

• Western Blot Considerations:

  • Strip and reprobe membranes sequentially rather than simultaneous detection

  • Use total H3 antibody as loading control

  • Consider phosphatase treatment as negative control

  • Validate that stripping does not affect protein retention on membranes

Researchers should note that high-quality multiplexed data often requires optimization of each parameter for the specific combination of modifications being studied, as protocols optimized for individual antibodies may not be directly transferable to multiplexed settings.

How should I design experiments to study the relationship between Histone H3 Thr6 phosphorylation and other epigenetic modifications?

To investigate how H3T6 phosphorylation interacts with other epigenetic modifications:

• Sequential ChIP (re-ChIP) Approach:

  • First, immunoprecipitate with pH3T6 antibody

  • Elute bound complexes under mild conditions

  • Perform second immunoprecipitation with antibodies against other modifications

  • Include appropriate controls (IgG, input, reverse order of antibodies)

  • Analyze enrichment at specific genomic regions using qPCR or sequencing

• Mass Spectrometry-Based Approaches:

  • Extract histones using acid extraction (0.2M H₂SO₄) or specialized histone purification kits

  • Perform propionylation of lysine residues to improve peptide detection

  • Digest with trypsin to generate peptides containing T6

  • Analyze using liquid chromatography-tandem mass spectrometry (LC-MS/MS)

  • Quantify co-occurrence of T6 phosphorylation with other modifications on the same peptide

  • Use synthetic peptide standards for accurate quantification

• Cell Synchronization Strategies:

  • Use thymidine block or nocodazole treatment for cell cycle synchronization

  • Collect samples at defined time points during cell cycle progression

  • Analyze dynamics of multiple histone modifications simultaneously

  • Correlate with cell cycle markers (e.g., Cyclin B, pH3S10)

• Pharmacological Approaches:

  • Test the effect of specific kinase inhibitors on multiple histone modifications

  • Include compounds targeting pathways known to regulate H3 phosphorylation (e.g., Aurora kinases, CDK1, Haspin)

  • Analyze dose-dependent and time-dependent effects

  • Consider combinatorial treatment to identify potential synergistic or antagonistic relationships